The Role of the EKG in Anticancer Drug Development

Completed

Conditions studied: Advanced Cancer

In brief

Primary Objective: -Evaluate incidence of cardiac complications in Phase I patients. Secondary Objective: -To identify variables (i.e. number of electrocardiograms (EKG) performed) that lead to the detection of cardiac events.

Key facts

Study ID

NCT01462383

Run by

M.D. Anderson Cancer Center

People needed

525

Starts

2011-01-01

Expected to finish

2011-11-01

Last updated by the study team

2011-12-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All types of advanced cancer

You may not qualify if…

• N/A

Where it is running

• UT MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.